Sorry, you need to enable JavaScript to visit this website.

Categories

Keywords

  • All Keywords
November 2023
October 2023

Press Kits

These downloadable files, including fact sheets about Pfizer and approved images or videos, are packages curated by the Global Media Relations team for use by professional journalists.

View Press Kits

Media Contacts

United States, Canada, and Latin America
+1 212.733.1226

Europe, Middle East, and Africa
+44-(0)845.300.8033

Asia Pacific
+65.918.732.47

Email
[email protected]

Though intended for professional media, these resources may also be interesting to patients, healthcare professionals, and investors. The media relations team is focused on responding to media inquiries. However, we want to ensure that customers, investors, and others receive the appropriate attention.

For patients or healthcare professionals with questions about Pfizer’s vaccines or medicines, please see our global list of medical information contacts.

For investors with questions about Pfizer’s efforts, please visit our contact page and select "Shareholder Services".

For all other non-media inquiries, please visit the contact us page to reach the appropriate Pfizer contact.

Programs & Initiatives The Future of Pharmacovigilance: Monitoring Medicine and Vaccine Safety Using AI and Other Tech Since 2014, Pfizer has used artificial intelligence to help sort through and categorize reports that people file when they experience an “adverse event.” Programs & Initiatives The Importance of Returning Clinical Trial Data to Participants Pfizer is providing participants with their own clinical trial data when an eligible trial ends via the Clinical Trial Participant Data Return Initiative. Science & Innovation Mathematical Sandbox: How Quantitative Systems Pharmacology Steers Safer, Faster Drug Development Quantitative systems pharmacology gets medicine to patients quicker, improves how well they work, and minimizes patient risk—especially for new treatments.